People worry during pandemics and their worries often lead them to contact already overstretched health services.
A 50-year-old man comes to see you with a chesty cough. He has no previous medical illnesses. On examination his temperature is normal and his chest is clear. You are about to reassure him when he says that he returned from a trip to the Middle East three weeks ago.
He left it to the last minute to tell you – but he is quite worried that he might have Middle East Respiratory Syndrome (MERS). So what should you do? Should you be worried as well?
The short answer is that he is unlikely to have MERS. He just has a cough. He has no fever or other physical signs and has no risk factors. Also, he left the Middle East more than two weeks ago. Lastly, MERS is rare - colds and flus are much more common. He is more likely to have a cold or flu than MERS. But there is a long answer to this question also.
People worry during pandemics and their worries often lead them to contact already overstretched health services. They frequently do not have the infection that they are worried about, but ironically they can pick up other infections in emergency department waiting areas. And long queues make it even more difficult for healthcare professionals to promptly diagnose and treat patients who are seriously ill.
So what can we do about the worried well? Ro et al have come up with an interesting answer (1). They conducted a cross-sectional survey of disease-related worry during the MERS outbreak in Korea. They found lots of worried people. More specifically they found that women and those with “poor subjective health status had higher levels of worry”.
People who were stressed were also more likely to worry, as were those who trusted informal information. Informal information probably includes scare stories and rumours. Interestingly they found that “the level of worry in the initial stage was closely associated with the levels during the stages that followed.”
They drew some clear conclusions – which probably have implications for other pandemics. Public information messages should be tailored and targeted to different groups of people.
Evidence based formal public information should be made widely available to dispel myths and informal information. And lastly, interventions to manage the level of worry in the early stages should help in the longer term. These are ideas worth thinking about now – as we approach the annual influenza season.
1. Ro J-S, Lee J-S, Kang S-C, Jung H-M (2017) Worry experienced during the 2015 Middle East Respiratory Syndrome (MERS) pandemic in Korea. PLoS ONE 12(3): e0173234.
This opinion piece was authored by BMJ Clinical Director, Dr Kieran Walsh. The purpose of this document is to educate and to inform. The content of this document does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the author's. BMJ does not endorse any views or recommendations expressed in this document. Readers should also be aware that professionals in the field may have different opinions. Users of this document hereby agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
The actors involved in global health are changing, and a multi-sectoral, cross-cutting approach is essential for tackling the priority issues.
We have extensive experience in bringing together thought leaders, policy makers, healthcare professionals and senior stakeholders from all sectors with an interest and mission for improving global health and global health security.Our programme of events collectively attracts more than 10,000 delegates annually from over 85 countries, including:
Mitali Wroczynski works closely with ministries of health, agriculture, and defence to influence policy decision-making, and develop new global health partnerships.
She pioneered BMJ’s clinical decision support training initiative that supports healthcare professionals working in low and middle-income countries to improve the detection, diagnosis, and management of infectious diseases and contributes to building health system resilience. Mitali has also played a key role in making risk communication a central issue for managing major infectious disease outbreaks, epidemics or pandemics, as part of the EU-funded programme, TELL ME.
Contact Mitali to find out how together we can address global health and global health securities priorities:
Head of Strategic Partnerships, Global Health & Global Health Security
Tel: +44 (0) 20 7383 6517
The Practical Approach to Care Kit (PACK) is a clinical decision support programme guides primary healthcare clinicians through the diagnosis and management process of more than 500 common symptoms and conditions, including:
This four pillar training programme improves primary health care in low and middle income countries. It works most effectively by partnering with governments, universities and NGOs to partner with us. Provide PACK to your clinicians working in remote areas today by contacting Dr. Tracy Eastman.
Dr Tracy Eastman, KTU Director of PACK Global Development and Delivery
Tel: +44 (0) 208 872 6323